Free Trial

Indonesia Has Spent Quarter Of 2021 Recovery Budget, Launches Private Vaccination Scheme

IDR

Spot USD/IDR has extended its rally and last sits +15 figs at IDR14,298. Continued upswing above the 200-DMA at IDR14,399 would bode well for the bullish case. Conversely, a retreat under the 100-DMA at IDR14,248 would bring May 10 low of IDR14,145 into view.

  • USD/IDR 1-month NDF has shed 25 figs and trades at IDR14,362 as we type. Below trendline support at IDR14,292 opens May 7 cycle low of IDR14,133. Topside focus falls on May 13 high of IDR14,403, followed by the 200-DMA at IDR14,448.
  • Indonesian Econ Min Hartarto said that the gov't has spent IDR172.35tn under its recovery budget for this year, which is equivalent to 24.6% of the entire 2021 recovery spending plan. Hartart added that the gov't expects a Q2 GDP growth of ~7% Y/Y.
  • Indonesia launched its private vaccination programme using Sinopharm jabs at 20 m'fing sites across greater Jakarta. Over 20,000 companies have registered in the scheme.
  • The Jakarta Post reported that a state-led study suggested that the Sinovac product, which is the cornerstone of nationwide immunisation programme, is 95% effective in preventing hospitalisation and death from Covid-19.
  • On the data front, Indonesian trade balance comes out Thursday.

To read the full story

Close

Why MNI

MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.